BIIB

MKT CAP:$28B

Biogen Inc

Market Cap

$28B

Healthcare·Drug Manufacturers - General·🇺🇸 United States·NASDAQ

Healthcare·Drug Mfg.·🇺🇸·NASDAQ

Stock Price

$192.62+$14.80 (+8.32%)

Jun 8, 2026

52W High $204.5352W Low $122.68

Company Details

Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPI...

CEO

—

IPO Date

Sep 16, 1991

Website

www.biogen.com

Key Metrics TTM

Revenue

$9.9B

+0.4% YoY

Net Income

$1.4B

EPS (Diluted)

Free Cash Flow

$2.6B

Revenue / Share

$66.42

Gross Margin

69.8%

Operating Margin

15.6%

Net Margin

13.9%

FCF Margin

26.6%

P/S

2.9x

P/E

20.7x

Earnings Reports

Q2 2026

Jul 30, 2026

PENDING

Q1 2026

Apr 29, 2026

$2.5B+1.9%

FY 2025

Feb 6, 2026

$9.8B+1.4%

Q4 2025

Feb 6, 2026

$2.3B-7.1%

Q3 2025

Oct 30, 2025

$2.5B-0.4%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee